Recommend reads: FDA SVF warning, big Aspen grant, CSI finale invokes stem cells
Professor Paul Knoepfler, Ph.D.
One of the most contentious areas in the regenerative medicine arena is whether a fat tissue product called stromal vascular fraction or SVF is a drug. The FDA says SVF, even in autologous form, is a drug. It is seeking an injunction against a California-based network of SVF clinics but lost the initial case. That […] The post Recommend reads: FDA SVF warning, big Aspen grant, CSI finale invokes stem cells appeared first on The Niche .